SQUARE has invested in state of the art formulation plants aligned to regulated market standards. Six manufacturing units of the Dhaka site can produce pharmaceutical products maintaining cGMP requirement for highly regulated markets in Europe, Australia and USA. Other five manufacturing units at Pabna site are producing finished formulations targeting markets in ASEAN, SAARC and marketing in RoW region. We have 700 product approvals for export markets and 900 product approvals for Bangladesh market.

Present Markets

SQUARE Pharmaceuticals Ltd. is already supplying products to the following markets:

Europe: UK, Denmark, The Netherlands

Asia: Afghanistan, Bhutan, Cambodia, Fiji, Hong Kong, Iraq, Korea, Macau, Malaysia, Maldives, Myanmar, Nepal, Papua New Guinea, Palau, Sri Lanka, Tajikistan, The Philippines, Uzbekistan, Vietnam

Africa: Eritrea, Ivory Coast, Kenya, Libya, Malawi, Mauritania, Mauritius, Mozambique, Nigeria, Somalia, Tanzania, Uganda 

Central and South America: Belize, Costa Rica, Suriname

Highlights of the Export Operations
We export to following countries:
We are approved by
  UK-MHRA and TGA-Australia

Contact Us
  International Marketing Department
  Square Centre
  Square Pharmaceuticals Ltd.
  48, Mohakhali Commercial Area
  Dhaka 1212. Bangladesh

  Telephone: 880 2 9859007
  Fax: 880 2 8834941
  Email: intlmkt@squaregroup.com

Join us on